Standpoint Research Downgrades Pfizer (PFE) to Hold; Valuation Call
Tweet Send to a Friend
Standpoint Research downgraded Pfizer (NYSE: PFE) from Buy to Hold.
Standpoint analyst, Ronnie Moas, said, "PFE shares are up 61 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Standpoint analyst, Ronnie Moas, said, "PFE shares are up 61 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
